LeadIQ logo
Learn more at LeadIQ.com

Insights

RNA-focused Therapies Eclipsebio specializes in developing technologies for RNA-based therapies, presenting an opportunity for collaboration with companies looking to enhance their RNA-targeting capabilities.

Revenue & Growth Potential With a revenue range of $0-10M and recent funding of $14M, Eclipsebio shows promise for growth potential, making them an attractive partner for organizations seeking innovative biotech solutions.

Tech Savvy Operations Utilizing a robust tech stack including MouseFlow, MariaDB, and Nginx, Eclipsebio demonstrates a commitment to cutting-edge technology, appealing to businesses looking for advanced solutions in biotechnology research.

Competitive Landscape While Eclipsebio operates in a competitive market with companies like QIAGEN and Illumina, its specialized focus on RNA therapies sets it apart, providing a unique selling point for targeted market positioning.

Industry Affiliations As part of the biotechnology research industry, Eclipsebio aligns with leading players such as Roche and Thermo Fisher Scientific, offering cross-collaboration opportunities within the sector for mutual business growth.

Similar companies to Eclipsebio

Eclipsebio Tech Stack

Eclipsebio uses 8 technology products and services including MouseFlow, TrackJs, MariaDB, and more. Explore Eclipsebio's tech stack below.

  • MouseFlow
    Analytics
  • TrackJs
    Analytics
  • MariaDB
    Database
  • Select2
    Javascript Libraries
  • Pantheon
    Platform As A Service
  • PHP
    Programming Languages
  • Yoast SEO Premium
    Search Engines
  • Nginx
    Web Servers

Media & News

Eclipsebio's Email Address Formats

Eclipsebio uses at least 1 format(s):
Eclipsebio Email FormatsExamplePercentage
First.Last@eclipsebio.comJohn.Doe@eclipsebio.com
36%
First@eclipsebio.comJohn@eclipsebio.com
16%
Last@eclipsebio.comDoe@eclipsebio.com
12%
First.Last@eclipsebio.comJohn.Doe@eclipsebio.com
36%

Frequently Asked Questions

Where is Eclipsebio's headquarters located?

Minus sign iconPlus sign icon
Eclipsebio's main headquarters is located at 5770 Oberlin Dr San Diego, California 92121 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Eclipsebio's official website and social media links?

Minus sign iconPlus sign icon
Eclipsebio's official website is eclipsebio.com and has social profiles on LinkedIn.

How much revenue does Eclipsebio generate?

Minus sign iconPlus sign icon
As of October 2024, Eclipsebio's annual revenue reached $1.8M.

What is Eclipsebio's SIC code NAICS code?

Minus sign iconPlus sign icon
Eclipsebio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eclipsebio have currently?

Minus sign iconPlus sign icon
As of October 2024, Eclipsebio has approximately 39 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President Of Sales: M. F.Head Of Commercial: R. O.Head Of Platform: W. D.. Explore Eclipsebio's employee directory with LeadIQ.

What industry does Eclipsebio belong to?

Minus sign iconPlus sign icon
Eclipsebio operates in the Biotechnology Research industry.

What technology does Eclipsebio use?

Minus sign iconPlus sign icon
Eclipsebio's tech stack includes MouseFlowTrackJsMariaDBSelect2PantheonPHPYoast SEO PremiumNginx.

What is Eclipsebio's email format?

Minus sign iconPlus sign icon
Eclipsebio's email format typically follows the pattern of . Find more Eclipsebio email formats with LeadIQ.

How much funding has Eclipsebio raised to date?

Minus sign iconPlus sign icon
As of October 2024, Eclipsebio has raised $14M in funding. The last funding round occurred on Mar 15, 2022 for $14M.

When was Eclipsebio founded?

Minus sign iconPlus sign icon
Eclipsebio was founded in 2017.
Eclipsebio

Eclipsebio

Biotechnology ResearchCalifornia, United States11-50 Employees

Eclipsebio develops first-in-class technologies, analyses, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies. With our extensive experience in supporting early-stage basic research to evaluating preclinical vaccines and gene therapies, we provide unparalleled support for obtaining deep insights into RNA and therapeutic biology. We offer our solutions as end-to-end partnerships, including custom assay development, for biopharma and biotech companies and as a la carte services.

Our areas of support include:
- The optimization and characterization of RNA-based vaccines and therapeutics through our eMERGE platform
- Multiomic characterization of small molecule and small oligonucleotide targets
- Robust validation of on-target, and the identification of off-target, effects from small molecule and small oligonucleotide drugs
- Deep profiling of RNA for groundbreaking discoveries in academic research

Contact us today to discover how we can provide you with the insights needed for RNA success.

Section iconCompany Overview

Headquarters
5770 Oberlin Dr San Diego, California 92121 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $14M

    Eclipsebio has raised a total of $14M of funding over 2 rounds. Their latest funding round was raised on Mar 15, 2022 in the amount of $14M.

  • $10M

    Eclipsebio's revenue is in the range of $10M

Section iconFunding & Financials

  • $14M

    Eclipsebio has raised a total of $14M of funding over 2 rounds. Their latest funding round was raised on Mar 15, 2022 in the amount of $14M.

  • $10M

    Eclipsebio's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.